seth_ablordeppey_web.jpgTALLAHASSEE — Seth Ablordeppey, a Florida A&M University (FAMU) professor in the College of Pharmacy and Pharmaceutical Sciences, has received a United States patent (No. 8,158,646) for extensive modifications to the drug Cryptolepine.

Preliminary tests indicate the drug will be effective at treating infections commonly found in HIV/AIDS, chemotherapy, and organ transplant patients.

In addition, it has fewer side effects than several currently used drugs.

“This research has been in the works for more than a decade and I am grateful to FAMU for providing the environment and opportunity for this discovery,” said Ablordeppey.Cryptolepine is a series of compounds derived from a native plant of Ghana, West Africa.

This is Ablordeppey’s second patent in two years. In 2010, he received a patent for developing the “Haloperidol Analog,” a method for treating mammals suffering psychosis.

Photo: Seth Ablordeppey